Synergy Innovation Co. Ltd
Synergy Innovation Co., Ltd. engages in the research and development, and investment of generic and new drugs, medical devices, and health functional foods in South Korea. It produces and sells various culture media for hospitals, pharmaceuticals, and food/cosmetics; manufactures synergy innovation " universal transport solutions (SI-UTS); and invests and develops in various fields comprising mic… Read more
Synergy Innovation Co. Ltd (048870) - Net Assets
Latest net assets as of September 2025: ₩267.96 Billion KRW
Based on the latest financial reports, Synergy Innovation Co. Ltd (048870) has net assets worth ₩267.96 Billion KRW as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (₩335.45 Billion) and total liabilities (₩67.50 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ₩267.96 Billion |
| % of Total Assets | 79.88% |
| Annual Growth Rate | 2.78% |
| 5-Year Change | 130.71% |
| 10-Year Change | N/A |
| Growth Volatility | 62.01 |
Synergy Innovation Co. Ltd - Net Assets Trend (2006–2024)
This chart illustrates how Synergy Innovation Co. Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Synergy Innovation Co. Ltd (2006–2024)
The table below shows the annual net assets of Synergy Innovation Co. Ltd from 2006 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ₩182.74 Billion | -17.90% |
| 2023-12-31 | ₩222.59 Billion | +59.09% |
| 2022-12-31 | ₩139.91 Billion | +22.80% |
| 2021-12-31 | ₩113.94 Billion | +43.85% |
| 2020-12-31 | ₩79.21 Billion | +5.53% |
| 2019-12-31 | ₩75.05 Billion | +39.52% |
| 2018-12-31 | ₩53.79 Billion | +74.02% |
| 2017-12-31 | ₩30.91 Billion | +129.54% |
| 2016-12-31 | ₩13.47 Billion | +168.84% |
| 2015-12-31 | ₩-19.56 Billion | -165.01% |
| 2014-12-31 | ₩30.09 Billion | -28.78% |
| 2013-12-31 | ₩42.26 Billion | -44.08% |
| 2012-12-31 | ₩75.56 Billion | +6.30% |
| 2011-12-31 | ₩71.09 Billion | -30.49% |
| 2009-12-31 | ₩102.27 Billion | -23.95% |
| 2008-12-31 | ₩134.48 Billion | +0.67% |
| 2007-12-31 | ₩133.58 Billion | +19.81% |
| 2006-12-31 | ₩111.49 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to Synergy Innovation Co. Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7288021878000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | ₩41.35 Billion | 22.63% |
| Other Components | ₩214.26 Billion | 117.25% |
| Total Equity | ₩182.74 Billion | 100.00% |
Synergy Innovation Co. Ltd Competitors by Market Cap
The table below lists competitors of Synergy Innovation Co. Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Licogi 16 JSC
VN:LCG
|
$80.27 Million |
|
Genelux Corporation Common Stock
NASDAQ:GNLX
|
$80.28 Million |
|
Oxford Bank Corporation
PINK:OXBC
|
$80.28 Million |
|
Biomea Fusion Inc
NASDAQ:BMEA
|
$80.34 Million |
|
Jinzhou Port Co Ltd A
SHG:600190
|
$80.24 Million |
|
Blackfinch Spring VCT PLC
LSE:BFSP
|
$80.22 Million |
|
Info-Tek
TWO:8183
|
$80.21 Million |
|
Parrot
PINK:PAOTF
|
$80.19 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Synergy Innovation Co. Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 178,049,241,670 to 182,735,808,750, a change of 4,686,567,080 (2.6%).
- Net income of 10,370,684,400 contributed positively to equity growth.
- Dividend payments of 1,230,054,240 reduced retained earnings.
- Share repurchases of 277,977,760 reduced equity.
- New share issuances of 277,977,760 increased equity.
- Other factors decreased equity by 4,454,063,080.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ₩10.37 Billion | +5.68% |
| Dividends Paid | ₩1.23 Billion | -0.67% |
| Share Repurchases | ₩277.98 Million | -0.15% |
| Share Issuances | ₩277.98 Million | +0.15% |
| Other Changes | ₩-4.45 Billion | -2.44% |
| Total Change | ₩- | 2.63% |
Book Value vs Market Value Analysis
This analysis compares Synergy Innovation Co. Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.95x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 6.90x to 0.95x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2016-12-31 | ₩303.42 | ₩2095.00 | x |
| 2017-12-31 | ₩559.53 | ₩2095.00 | x |
| 2018-12-31 | ₩936.73 | ₩2095.00 | x |
| 2019-12-31 | ₩1152.75 | ₩2095.00 | x |
| 2020-12-31 | ₩1080.44 | ₩2095.00 | x |
| 2021-12-31 | ₩1432.55 | ₩2095.00 | x |
| 2022-12-31 | ₩1691.63 | ₩2095.00 | x |
| 2023-12-31 | ₩2152.74 | ₩2095.00 | x |
| 2024-12-31 | ₩2209.40 | ₩2095.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Synergy Innovation Co. Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 5.68%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 11.45%
- • Asset Turnover: 0.29x
- • Equity Multiplier: 1.72x
- Recent ROE (5.68%) is above the historical average (4.03%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 23.56% | 13.74% | 1.39x | 1.23x | ₩15.04 Billion |
| 2007 | 1.47% | 1.58% | 0.80x | 1.17x | ₩-11.39 Billion |
| 2008 | 2.10% | 2.99% | 0.53x | 1.33x | ₩-10.62 Billion |
| 2014 | -40.59% | -39.02% | 0.38x | 2.73x | ₩-15.21 Billion |
| 2015 | 0.00% | -345.14% | 0.92x | 0.00x | ₩-49.37 Billion |
| 2016 | 101.51% | 87.53% | 0.26x | 4.43x | ₩12.32 Billion |
| 2017 | -30.03% | -27.14% | 0.32x | 3.43x | ₩-12.37 Billion |
| 2018 | -2.52% | -3.22% | 0.34x | 2.27x | ₩-6.73 Billion |
| 2019 | 4.46% | 6.13% | 0.37x | 1.96x | ₩-4.16 Billion |
| 2020 | -27.03% | -31.06% | 0.44x | 2.00x | ₩-29.33 Billion |
| 2021 | 5.02% | 18.63% | 0.15x | 1.78x | ₩-5.67 Billion |
| 2022 | 11.53% | 18.64% | 0.38x | 1.63x | ₩2.14 Billion |
| 2023 | 1.29% | 2.77% | 0.29x | 1.61x | ₩-15.50 Billion |
| 2024 | 5.68% | 11.45% | 0.29x | 1.72x | ₩-7.90 Billion |
Industry Comparison
This section compares Synergy Innovation Co. Ltd's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $209,689,906,881
- Average return on equity (ROE) among peers: -10.47%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Synergy Innovation Co. Ltd (048870) | ₩267.96 Billion | 23.56% | 0.25x | $80.27 Million |
| ORIENTBIO Inc. (002630) | $67.35 Billion | -2.60% | 1.21x | $28.10 Million |
| Green Cross (005250) | $282.15 Billion | 18.83% | 0.53x | $228.88 Million |
| Green Cross Holdings Preference Shares (005257) | $1.44 Trillion | 3.01% | 0.78x | $410.72 Million |
| Pharmicell (005690) | $9.90 Billion | -119.73% | 2.00x | $438.14 Million |
| GeneOne Life Science Inc (011000) | $39.74 Billion | 0.00% | 0.49x | $53.78 Million |
| HLB Co. Ltd (028300) | $77.24 Billion | -21.40% | 1.44x | $4.11 Billion |
| Daesung Microbiological Labs. Co. Ltd (036480) | $25.09 Billion | 18.13% | 0.29x | $14.92 Million |
| Seoulin Bioscience Co.Ltd (038070) | $51.49 Billion | 4.00% | 0.38x | $27.72 Million |
| Hyundai Bioscience Co. Ltd (048410) | $39.30 Billion | 0.00% | 0.56x | $899.28 Million |
| iNtRON Biotechnology Inc (048530) | $64.96 Billion | -4.91% | 0.37x | $83.99 Million |